InsiderDB

Rep. Daniel S. Goldman sold Amicus Therapeutics (FOLD)

Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Apr 10, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Apr 10, 2023
Disclosed
May 19, 2023
Days to disclose
39
Asset type
Stock
As filed
Amicus Therapeutics, Inc.
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Goldman's trades →

Company context for FOLD

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. FOLDLobbying report·Lobbying disclosures

    FOLD: second_quarter 2026 lobbying report

    Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases. Legislative and regulatory issues affecting SMID rare disease biotech companies.

    Public: Jul 16, 2026, 3:36 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.